Janssen Rebrands as Johnson & Johnson Innovative Medicine Amid Global Business Integration

On September 14, Johnson & Johnson announced a brand update, under which its two major businesses—medical technology and pharmaceuticals—will be integrated under the Johnson & Johnson name. The pharmaceutical division, Janssen, will be renamed Johnson & Johnson Innovative Medicine, while the medical technology division will remain unchanged.

Johnson & Johnson's brand renewal this time is mainly reflected in the updates of the brand logo, color tone, connection symbols, and artistic design. The new brand is built on the company's traditions, highlighting the modernity of key elements more prominently, showcasing its healthcare innovations in an inclusive manner, and bringing the company's warm and caring essence to life.

Chairman and Chief Executive Officer Joaquin Duato stated: "Johnson & Johnson's focus on innovative pharmaceuticals and medical technology enables continuous innovation in the healthcare field. The integration of diversified businesses under a new brand also demonstrates Johnson & Johnson's unique ability to reshape healthcare through transformative innovation, while staying true to our credo values and fully meeting the needs of patients and doctors."

Copyright © 2023 PHARMCUBE. All Rights Reserved.

Welcome to forward, share, and reasonably cite. When citing, please clearly indicate the source of the article in a prominent position; if you need to reprint, please leave a message or send a message to the WeChat Official Account backend, and specify the name and ID of the official account.

Disclaimer: The information in this WeChat article is for general reference only and should not be directly used as decision-making content. PharmaCube assumes no responsibility for any loss incurred by any party due to the use of the content herein.

Highlights Preview

Online Live Streaming & Offline Salon

↑ Long press to scan the QR code and sign up for the event ↑